News

02/07/2024 - Innovation, Projects, Research, Success Stories

IGTP and DevsHealth join forces to develop new antibiotics against hospital-acquired infections by multi-resistant Staphylococcus aureus

DevsHealth, a leading company in artificial intelligence (AI) driven drug discovery, and the Germans Trias i Pujol Research Institute (IGTP), a public research centre in biomedical sciences, have announced a new partnership to develop new antibiotics for multi-resistant Staphylococcus aureus infections.

20/06/2024 - Research

New cellular models of myotonic dystrophy type 1 reflect the clinical diversity of the disease

Cellular models used to search for new therapies for myotonic dystrophy type 1 do not usually take into account the diversity of subtypes presented by patients. A study led by researchers from IGTP has taken a step forward by developing three new models that represent this heterogeneity. The results have been published in the journal iScience.